Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name PSB205
Trade Name
Synonyms PSB-205|PSB 205|QL-1706|QL 1706|QL1706
Drug Descriptions

PSB205 comprises the combination of a monoclonal antibody targeting CD274 (PD-L1) and a monoclonal antibody CTLA4, which has potential anti-tumor activity (J Clin Oncol 40, 2022 (suppl 16; abstr 2611)).

DrugClasses CTLA4 Antibody 31 PD-L1/PD-1 antibody 121
CAS Registry Number NA
NCIT ID C162774

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bevacizumab + Carboplatin + Pemetrexed Disodium + PSB205 Bevacizumab Carboplatin PSB205 Pemetrexed Disodium 0 0
Carboplatin + Paclitaxel + PSB205 Carboplatin PSB205 Paclitaxel 0 0
Carboplatin + Pemetrexed Disodium + PSB205 Carboplatin PSB205 Pemetrexed Disodium 0 0
PSB205 PSB205 0 1


Additional content available in CKB BOOST